British Society of Gastroenterology consensus guidelines on the management of inflammatory bowel disease in adults

Research electronic data capture (REDCap)—A metadata-driven methodology and workflow process for providing translational research informatics support

Harris, P. A., Taylor, R., Thielke, R., Payne, J., Gonzalez, N., & Conde, J. G. (2009) · Journal of Biomedical Informatics · doi:10.1016/j.jbi.2008.08.010 · Cited by 51,384 · see citing works

GRADE: an emerging consensus on rating quality of evidence and strength of recommendations

Guyatt, G. H., Oxman, A. D., Vist, G. E., Kunz, R., Falck-Ytter, Y., Alonso-Coello, P., & Schünemann, H. J. (2008) · BMJ · doi:10.1136/bmj.39489.470347.ad · Cited by 23,305 · see citing works

Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial

Hanauer, S. B., Feagan, B. G., Lichtenstein, G. R., Mayer, L., Schreiber, S., Colombel, J., Rachmilewitz, D., Wolf, D. C., Olson, A. D., Bao, W., et al. (2002) · The Lancet · doi:10.1016/s0140-6736(02)08512-4 · Cited by 4,164 · see citing works

Infliximab for Induction and Maintenance Therapy for Ulcerative Colitis

Rutgeerts, P. J., Sandborn, W. J., Feagan, B. G., Reinisch, W., Olson, A. D., Johanns, J., Travers, S., Rachmilewitz, D., Hanauer, S. B., Lichtenstein, G. R., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa050516 · Cited by 3,910 · see citing works

AGREE II: advancing guideline development, reporting and evaluation in health care

Brouwers, M. C., Kho, M. E., Browman, G. P., Burgers, J. S., Cluzeau, F., Feder, G., Fervers, B., Graham, I. D., Grimshaw, J., Hanna, S. E., et al. (2010) · Canadian Medical Association Journal · doi:10.1503/cmaj.090449 · Cited by 3,790 · see citing works

Radiation exposure from CT scans in childhood and subsequent risk of leukaemia and brain tumours: a retrospective cohort study

Pearce, M. S., Salotti, J. A., Little, M. P., McHugh, K., Lee, C., Kim, K. P., Howe, N. L., Ronckers, C. M., Rajaraman, P., Craft, A. W., et al. (2012) · The Lancet · doi:10.1016/s0140-6736(12)60815-0 · Cited by 3,735 · see citing works

Toward an Integrated Clinical, Molecular and Serological Classification of Inflammatory Bowel Disease: Report of a Working Party of the 2005 Montreal World Congress of Gastroenterology

Silverberg, M. S., Satsangi, J., Ahmad, T., Arnott, I. D., Bernstein, C. N., Brant, S. R., Caprilli, R., Colombel, J., Gasché, C., Geboes, K., et al. (2005) · Canadian Journal of Gastroenterology · doi:10.1155/2005/269076 · Cited by 3,408 · see citing works

The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications

Satsangi, J., Silverberg, M. S., Vermeire, S., & Colombel, J.-F. (2006) · Gut · doi:10.1136/gut.2005.082909 · Cited by 3,173 · see citing works

Infliximab, Azathioprine, or Combination Therapy for Crohn's Disease

Colombel, J., Sandborn, W. J., Reinisch, W., Mantzaris, G. J., Kornbluth, A. A., Rachmilewitz, D., Lichtiger, S., D’Haens, G., Diamond, R. H., Broussard, D. L., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0904492 · Cited by 3,140 · see citing works

Coated Oral 5-Aminosalicylic Acid Therapy for Mildly to Moderately Active Ulcerative Colitis

Schroeder, K. W., Tremaine, W. J., & Ilstrup, D. M. (1987) · New England Journal of Medicine · doi:10.1056/nejm198712243172603 · Cited by 3,037 · see citing works

A SIMPLE INDEX OF CROHN'S-DISEASE ACTIVITY

Harvey, R. F., & Bradshaw, J. M. (1980) · The Lancet · doi:10.1016/s0140-6736(80)92767-1 · Cited by 2,974 · see citing works

The risk of colorectal cancer in ulcerative colitis: a meta-analysis

Eaden, J., Abrams, K. R., & Mayberry, J. F. (2001) · Gut · doi:10.1136/gut.48.4.526 · Cited by 2,948 · see citing works

Vedolizumab as Induction and Maintenance Therapy for Ulcerative Colitis

Feagan, B. G., Rutgeerts, P. J., Sands, B. E., Hanauer, S. B., Colombel, J., Sandborn, W. J., Assche, G. V., Axler, J. L., Kim, H. J., Danese, S., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1215734 · Cited by 2,892 · see citing works

Cortisone in Ulcerative Colitis

Truelove, S. C., & Witts, L. J. (1955) · BMJ · doi:10.1136/bmj.2.4947.1041 · Cited by 2,793 · see citing works

Infliximab for the Treatment of Fistulas in Patients with Crohn's Disease

Present, D. H., Rutgeerts, P., Targan, S., Hanauer, S. B., Mayer, L., van Hogezand, R. A., Podolsky, D. K., Sands, B. E., Braakman, T., DeWoody, K. L., et al. (1999) · New England Journal of Medicine · doi:10.1056/nejm199905063401804 · Cited by 2,748 · see citing works

Vedolizumab as Induction and Maintenance Therapy for Crohn's Disease

Sandborn, W. J., Feagan, B. G., Rutgeerts, P. J., Hanauer, S. B., Colombel, J., Sands, B. E., Lukáš, M., Fedorak, R. N., Lee, S., Bressler, B. L., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1215739 · Cited by 2,716 · see citing works

Adalimumab for Maintenance of Clinical Response and Remission in Patients With Crohn’s Disease: The CHARM Trial

Colombel, J., Sandborn, W. J., Rutgeerts, P. J., Enns, R. A., Hanauer, S. B., Panaccione, R., Schreiber, S., Byczkowski, D., Li, J., Kent, J. D., et al. (2006) · Gastroenterology · doi:10.1053/j.gastro.2006.11.041 · Cited by 2,239 · see citing works

Waist circumference and abdominal sagittal diameter: best simple anthropometric indexes of abdominal visceral adipose tissue accumulation and related cardiovascular risk in men and women.

Pouliot, M.-C., Despres, J., Lemieux, S., Moorjani, S., Bouchard, C., Tremblay, A., Nadeau, A., & Lupien, P. (1994) · American Journal of Cardiology · doi:10.1016/0002-9149(94)90676-9 · Cited by 2,238 · see citing works

Infliximab Maintenance Therapy for Fistulizing Crohn's Disease

Sands, B. E., Anderson, F., Bernstein, C. N., Chey, W. Y., Feagan, B. G., Fedorak, R. N., Kamm, M. A., Korzenik, J. R., Lashner, B. A., Onken, J. E., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa030815 · Cited by 2,222 · see citing works

Classification of Inflammatory Bowel Disease

Lennard‐Jones, J. E. (1989) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365528909091339 · Cited by 2,022 · see citing works

Ulcerative Colitis Practice Guidelines in Adults: American College of Gastroenterology, Practice Parameters Committee

Kornbluth, A. A., & Sachar, D. B. (2010) · The American Journal of Gastroenterology · doi:10.1038/ajg.2009.727 · Cited by 2,019 · see citing works

Ustekinumab as Induction and Maintenance Therapy for Crohn’s Disease

Feagan, B. G., Sandborn, W. J., Gasink, C., Jacobstein, D., Lang, Y., Friedman, J. R., BLANK, M. A., Johanns, J., Gao, L.-L., Ye, M., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1602773 · Cited by 1,851 · see citing works

Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE): Determining Therapeutic Goals for Treat-to-Target

Peyrin‐Biroulet, L., Sandborn, W. J., Sands, B. E., Reinisch, W., Bemelman, W. A., Bryant, R. V., D’Haens, G., Dotan, I., Dubinsky, M. C., Feagan, B. G., et al. (2015) · The American Journal of Gastroenterology · doi:10.1038/ajg.2015.233 · Cited by 1,843 · see citing works

Predictability of the postoperative course of Crohn's disease

Rutgeerts, P., Geboes, K., Vantrappen, G., Beyls, J., Kerremans, R., & Hiele, M. I. (1990) · Gastroenterology · doi:10.1016/0016-5085(90)90613-6 · Cited by 1,814 · see citing works

Ulcerative Colitis and Colorectal Cancer

Ekbom, A., Helmick, C. G., Zack, M. M., & Adami, H. (1990) · New England Journal of Medicine · doi:10.1056/nejm199011013231802 · Cited by 1,794 · see citing works

Tofacitinib as Induction and Maintenance Therapy for Ulcerative Colitis

Sandborn, W. J., Su, C. G., Sands, B. E., D’Haens, G., Vermeire, S., Schreiber, S., Danese, S., Feagan, B. G., Reinisch, W., Niezychowski, W., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1606910 · Cited by 1,783 · see citing works

Development and validation of a new, simplified endoscopic activity score for Crohn's disease: the SES-CD

Daperno, M., D’Haens, G., Assche, G. V., Baert, F., Bulois, P., Maunoury, V., Sostegni, R., Rocca, R., Pera, A., Gevers, A., et al. (2004) · Gastrointestinal Endoscopy · doi:10.1016/s0016-5107(04)01878-4 · Cited by 1,779 · see citing works

Cyclosporine in Severe Ulcerative Colitis Refractory to Steroid Therapy

Lichtiger, S., Present, D. H., Kornbluth, A. A., Gelernt, I. M., Bauer, J. J., Galler, G. W., Michelassi, F., & Hanauer, S. B. (1994) · New England Journal of Medicine · doi:10.1056/nejm199406303302601 · Cited by 1,715 · see citing works

Human Anti–Tumor Necrosis Factor Monoclonal Antibody (Adalimumab) in Crohn’s Disease: the CLASSIC-I Trial

Hanauer, S. B., Sandborn, W. J., Rutgeerts, P. J., Fedorak, R. N., Lukáš, M., MacIntosh, D. G., Panaccione, R., Wolf, D. C., & Pollack, P. (2006) · Gastroenterology · doi:10.1053/j.gastro.2005.11.030 · Cited by 1,711 · see citing works

ESPEN guideline: Clinical nutrition in surgery.

Weimann, A., Braga, M., Carli, F., Higashiguchi, T., Hübner, M., Kłęk, S., Laviano, A., Ljungqvist, O., Lobo, D., Martindale, R., et al. (2017) · Clinical Nutrition · doi:10.1016/j.clnu.2017.02.013 · Cited by 1,665 · see citing works

2013 IDSA Clinical Practice Guideline for Vaccination of the Immunocompromised Host

Rubin, L. G., Levin, M. J., Ljungman, P., Davies, E. G., Avery, R., Tomblyn, M., Bousvaros, A., Dhanireddy, S., Sung, L., Keyserling, H., et al. (2014) · Clinical Infectious Diseases · doi:10.1093/cid/cit684 · Cited by 1,613 · see citing works

Pediatric modification of the Montreal classification for inflammatory bowel disease

Levine, A., Griffiths, A. M., Markowitz, J. F., Wilson, D. C., Turner, D., Russell, R. K., Fell, J. M. E., Ruemmele, F. M., Walters, T. D., Sherlock, M. E., et al. (2010) · Inflammatory Bowel Diseases · doi:10.1002/ibd.21493 · Cited by 1,518 · see citing works

Fracture Prevention With Vitamin D Supplementation

Bischoff-Ferrari, H. A., Willett, W. C., Wong, J. B., Giovannucci, E. L., Dietrich, T., & Dawson‐Hughes, B. (2005) · JAMA · doi:10.1001/jama.293.18.2257 · Cited by 1,514 · see citing works

Fecal Microbiota Transplantation Induces Remission in Patients With Active Ulcerative Colitis in a Randomized Controlled Trial

Moayyedi, P., Surette, M. G., Kim, P. T., Libertucci, J., Wolfe, M., Onischi, C., Armstrong, D., Marshall, J. K., Kassam, Z., Reinisch, W., et al. (2015) · Gastroenterology · doi:10.1053/j.gastro.2015.04.001 · Cited by 1,499 · see citing works

Oral bacteriotherapy as maintenance treatment in patients with chronic pouchitis: A double-blind, placebo-controlled trial

Gionchetti, P., Rizzello, F., Venturi, A., Brigidi, P., Matteuzzi, D., Bazzocchi, G., Poggioli, G., Miglioli, M., & Campieri, M. (2000) · Gastroenterology · doi:10.1053/gast.2000.9370 · Cited by 1,485 · see citing works

Guidelines for the management of inflammatory bowel disease in adults

Mowat, C., Cole, A., Windsor, A. C. J., Ahmad, T., Arnott, I. D., Driscoll, R., Mitton, S. G., Orchard, T. R., Rutter, M. D., Younge, L., et al. (2011) · Gut · doi:10.1136/gut.2010.224154 · Cited by 1,416 · see citing works

Article Commentary: Patient-Reported Outcomes (PROs) and Patient-Reported Outcome Measures (PROMs)

Weldring, T., & Smith, S. M. S. (2013) · Health Services Insights · doi:10.4137/hsi.s11093 · Cited by 1,367 · see citing works

Use of Inhaled Corticosteroids and Risk of Fractures

van Staa, T. P., Leufkens, H. G. M., & Cooper, C. C. (2001) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2001.16.3.581 · Cited by 1,297 · see citing works

The epidemiology of corticosteroid-induced osteoporosis: a meta-analysis

Staa, T. P. V., Staa, T. P. V., Staa, T. P. V., Leufkens, H. G. M., & Cooper, C. (2002) · Osteoporosis International · doi:10.1007/s001980200108 · Cited by 1,294 · see citing works

Multidonor intensive faecal microbiota transplantation for active ulcerative colitis: a randomised placebo-controlled trial

Paramsothy, S., Kamm, M. A., Kaakoush, N. O., Walsh, A. J., van den Bogaerde, J., Samuel, D., Leong, R. W. L., Connor, S., Ng, W., Paramsothy, R., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)30182-4 · Cited by 1,276 · see citing works

A practical guide to the monitoring and management of the complications of systemic corticosteroid therapy

Liu, D., Ahmet, A., Ward, L., Krishnamoorthy, P., Mandelcorn, E. D., Leigh, R., Brown, J. P., Cohen, A., & Kim, H. (2013) · Allergy, Asthma & Clinical Immunology · doi:10.1186/1710-1492-9-30 · Cited by 1,268 · see citing works

Adalimumab Induces and Maintains Clinical Remission in Patients With Moderate-to-Severe Ulcerative Colitis

Sandborn, W. J., Assche, G. V., Reinisch, W., Colombel, J., D’Haens, G., Wolf, D. C., Kron, M., Tighe, M. B., Lazar, A., & Thakkar, R. B. (2011) · Gastroenterology · doi:10.1053/j.gastro.2011.10.032 · Cited by 1,268 · see citing works

Use of oral corticosteroids and risk of fractures

Van Staa, T. P., Leufkens, H. G. M., Abenhaim, L., Zhang, B., & Cooper, C. (2000) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2000.15.6.993 · Cited by 1,263 · see citing works

Severity of inflammation is a risk factor for colorectal neoplasia in ulcerative colitis

Rutter, M., Saunders, B., Wilkinson, K., Rumbles, S., Schofield, G., Kamm, M., Williams, C., Price, A., Talbot, I., & Forbes, A. (2004) · Gastroenterology · doi:10.1053/j.gastro.2003.11.010 · Cited by 1,255 · see citing works

A Comparison of Vancomycin and Metronidazole for the Treatment of Clostridium difficile-Associated Diarrhea, Stratified by Disease Severity

Zar, F. A., Bakkanagari, S. R., Moorthi, K. M. L. S. T., & Davis, M. B. (2007) · Clinical Infectious Diseases · doi:10.1086/519265 · Cited by 1,247 · see citing works

European evidence-based Consensus on the prevention, diagnosis and management of opportunistic infections in inflammatory bowel disease

Rahier, J. F., Ben-Horin, S., Chowers, Y., Conlon, C., Munter, P. D., D’Haens, G., Domènech, E., Eliakim, R., Eser, A., Frater, J., et al. (2009) · Journal of Crohn s and Colitis · doi:10.1016/j.crohns.2009.02.010 · Cited by 1,247 · see citing works

National Cooperative Crohn's Disease Study: Results of drug treatment

Summers, R. W., Switz, D. M., Sessions, J. T., Becktel, J. M., Best, W. R., Kern, F., & Singleton, J. W. (1979) · Gastroenterology · doi:10.1016/0016-5085(79)90385-8 · Cited by 1,238 · see citing works

Prophylaxis of pouchitis onset with probiotic therapy: a double-blind, placebo-controlled trial

Gionchetti, P., Rizzello, F., Helwig, U., Venturi, A., Lammers, K. M., Brigidi, P., Vitali, B., Poggioli, G., Miglioli, M., & Campieri, M. (2003) · Gastroenterology · doi:10.1016/s0016-5085(03)00171-9 · Cited by 1,147 · see citing works

The natural history of corticosteroid therapy for inflammatory bowel disease: A population-based study

Faubion, W. A., Loftus, E. V., Harmsen, W. S., Zinsmeister, A. R., & Sandborn, W. J. (2001) · Gastroenterology · doi:10.1053/gast.2001.26279 · Cited by 1,144 · see citing works

Guidelines for colorectal cancer screening and surveillance in moderate and high risk groups (update from 2002)

Cairns, S. R., Scholefield, J. H., Steele, R. J., Dunlop, M. G., Thomas, H. J. W., Evans, D. G., Eaden, J., Rutter, M. D., Atkin, W. S., Saunders, B. P., et al. (2010) · Gut · doi:10.1136/gut.2009.179804 · Cited by 1,139 · see citing works

Mucosal Healing in Inflammatory Bowel Disease: Results From a Norwegian Population-Based Cohort

Frøslie, K. F., Jahnsen, J., Moum, B. A., & Vatn, M. H. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.05.051 · Cited by 1,121 · see citing works

Lymphoproliferative disorders in patients receiving thiopurines for inflammatory bowel disease: a prospective observational cohort study

Beaugerie, L., Brousse, N., Bouvier, A., Colombel, J. F., Lémann, M., Cosnes, J., Hébuterne, X., Cortot, A., Bouhnik, Y., Gendre, J., et al. (2009) · The Lancet · doi:10.1016/s0140-6736(09)61302-7 · Cited by 1,113 · see citing works

Expanded allogeneic adipose-derived mesenchymal stem cells (Cx601) for complex perianal fistulas in Crohn's disease: a phase 3 randomised, double-blind controlled trial

Panés, J., García‐Olmo, D., Assche, G. V., Colombel, J., Reinisch, W., Baumgart, D. C., Dignass, A. U., Nachury, M., Ferrante, M., Kazemi-Shirazi, L., et al. (2016) · The Lancet · doi:10.1016/s0140-6736(16)31203-x · Cited by 1,094 · see citing works

Infliximab as Rescue Therapy in Severe to Moderately Severe Ulcerative Colitis: A Randomized, Placebo-Controlled Study

Järnerot, G., Hertervig, E., Friis–Liby, I., Blomquist, L., Karlén, P., Grännö, C., VILIEN, M., Ström, M., Danielsson, Å., Verbaan, H., et al. (2005) · Gastroenterology · doi:10.1053/j.gastro.2005.03.003 · Cited by 1,092 · see citing works

Development, Validation, and Evaluation of a Pediatric Ulcerative Colitis Activity Index: A Prospective Multicenter Study

Turner, D., Otley, A. R., Mack, D. R., Hyams, J. S., de Bruijne, J., Uusoue, K., Walters, T. D., Zachos, M., Mamula, P., Beaton, D., et al. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.05.029 · Cited by 1,073 · see citing works

The EULAR points to consider for use of antirheumatic drugs before pregnancy, and during pregnancy and lactation

Skorpen, C. G., Hoeltzenbein, M., Tincani, A., Fischer‐Betz, R., Éléfant, É., Chambers, C., da Silva, J. A. P., Nelson‐Piercy, C., Cetin, I., Costedoat-Chalumeau, N., et al. (2016) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2015-208840 · Cited by 1,066 · see citing works

Risk Factors for Opportunistic Infections in Patients With Inflammatory Bowel Disease

Törüner, M., Loftus, E. V., Harmsen, W. S., Zinsmeister, A. R., Orenstein, R., Sandborn, W. J., Colombel, J., & Egan, L. J. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.01.012 · Cited by 1,014 · see citing works

Pharmacogenomics and metabolite measurement for 6-mercaptopurine therapy in inflammatory bowel disease

Dubinsky, M. C., Lamothe, S., Yang, H. Y., Targan, S. R., Sinnett, D., Théorêt, Y., & Seidman, E. G. (2000) · Gastroenterology · doi:10.1016/s0016-5085(00)70140-5 · Cited by 995 · see citing works

Strongyloides stercoralis in the Immunocompromised Population

Keiser, P. B., & Nutman, T. B. (2004) · Clinical Microbiology Reviews · doi:10.1128/cmr.17.1.208-217.2004 · Cited by 976 · see citing works

Combination Therapy With Infliximab and Azathioprine Is Superior to Monotherapy With Either Agent in Ulcerative Colitis

Panaccione, R., Ghosh, S. K., Middleton, S. J., et al. (2013) · Gastroenterology · doi:10.1053/j.gastro.2013.10.052 · Cited by 973 · see citing works

Use of the noninvasive components of the mayo score to assess clinical response in Ulcerative Colitis

Lewis, J. D., Chuai, S., Nessel, L. A., Lichtenstein, G. R., Aberra, F. N., & Ellenberg, J. H. (2008) · Inflammatory Bowel Diseases · doi:10.1002/ibd.20520 · Cited by 965 · see citing works

Adalimumab Induction Therapy for Crohn Disease Previously Treated with Infliximab

Sandborn, W. J., Rutgeerts, P. J., Enns, R., Hanauer, S. B., Colombel, J., Panaccione, R., D’Haens, G., Li, J., Rosenfeld, M. R., Kent, J. D., et al. (2007) · Annals of Internal Medicine · doi:10.7326/0003-4819-146-12-200706190-00159 · Cited by 961 · see citing works

Subcutaneous Golimumab Induces Clinical Response and Remission in Patients With Moderate-to-Severe Ulcerative Colitis

Sandborn, W. J., Feagan, B. G., Marano, C. W., Zhang, H., Strauss, R. S., Johanns, J., Adedokun, O. J., Guzzo, C. A., Colombel, J., Reinisch, W., et al. (2013) · Gastroenterology · doi:10.1053/j.gastro.2013.05.048 · Cited by 944 · see citing works

Comparison of scheduled and episodic treatment strategies of infliximab in Crohn’s disease

Rutgeerts, P. J., Feagan, B. G., Lichtenstein, G. R., Mayer, L., Schreiber, S., Colombel, J., Rachmilewitz, D., Wolf, D. C., Olson, A. D., Bao, W., et al. (2004) · Gastroenterology · doi:10.1053/j.gastro.2003.11.014 · Cited by 942 · see citing works

Impact of colonic cleansing on quality and diagnostic yield of colonoscopy: the European Panel of Appropriateness of Gastrointestinal Endoscopy European multicenter study

Froehlich, F., Wietlisbach, V., Gonvers, J., Burnand, B., & Vader, J.-P. (2005) · Gastrointestinal Endoscopy · doi:10.1016/s0016-5107(04)02776-2 · Cited by 933 · see citing works

European Cooperative Crohn's Disease Study (ECCDS): Results of drug treatment

Malchow, H. A., Ewe, K., Brandes, J. W., Goebell, H., Ehms, H., Sommer, H., & Jesdinsky, H. J. (1984) · Gastroenterology · doi:10.1016/0016-5085(84)90409-8 · Cited by 931 · see citing works

Effect of tight control management on Crohn's disease (CALM): a multicentre, randomised, controlled phase 3 trial

Colombel, J., Panaccione, R., Bossuyt, P. J., Lukáš, M., Baert, F., Vaňásek, T., Danalıoğlu, A., Novacek, G., Armuzzi, A., Hébuterne, X., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)32641-7 · Cited by 926 · see citing works

Second European evidence-based consensus on the prevention, diagnosis and management of opportunistic infections in inflammatory bowel disease

Rahier, J., Magro, F., Abreu, C., Armuzzi, A., Ben‐Horin, S., Chowers, Y., Cottone, M., de Ridder, L., Doherty, G. A., Ehehalt, R., et al. (2014) · Journal of Crohn s and Colitis · doi:10.1016/j.crohns.2013.12.013 · Cited by 925 · see citing works

Findings From a Randomized Controlled Trial of Fecal Transplantation for Patients With Ulcerative Colitis

Rossen, N. G., Fuentes, S., van der Spek, M. J., Tijssen, J. G., Hartman, J. H. A., Duflou, A., Löwenberg, M., van den Brink, G. R., Mathus-Vliegen, E. M. H., de Vos, W. M., et al. (2015) · Gastroenterology · doi:10.1053/j.gastro.2015.03.045 · Cited by 921 · see citing works

Early Mucosal Healing With Infliximab Is Associated With Improved Long-term Clinical Outcomes in Ulcerative Colitis

Colombel, J., Rutgeerts, P. J., Reinisch, W., Esser, D., Wang, Y., Lang, Y., Marano, C. W., Strauss, R. S., Oddens, B. J., Feagan, B. G., et al. (2011) · Gastroenterology · doi:10.1053/j.gastro.2011.06.054 · Cited by 918 · see citing works

Once daily high dose probiotic therapy (VSL#3) for maintaining remission in recurrent or refractory pouchitis

Mimura, T., Rizzello, F., Helwig, U., Poggioli, G., Schreiber, S., Talbot, I. C., Nicholls, R. J., Gionchetti, P., Campieri, M., & Kamm, M. A. (2003) · Gut · doi:10.1136/gut.53.1.108 · Cited by 912 · see citing works

Methotrexate for the Treatment of Crohn's Disease

Feagan, B. G., Rochon, J., Fedorak, R. N., Irvine, E. J., Wild, G., Sutherland, L. R., Steinhart, A. H., Greenberg, G. R., Gillies, R., Hopkins, M., et al. (1995) · New England Journal of Medicine · doi:10.1056/nejm199502023320503 · Cited by 909 · see citing works

Small-bowel capsule endoscopy and device-assisted enteroscopy for diagnosis and treatment of small-bowel disorders: European Society of Gastrointestinal Endoscopy (ESGE) Clinical Guideline

Pennazio, M., Spada, C., Eliakim, R., Keuchel, M., May, A. D., Mulder, C. J. J., Rondonotti, E., Adler, S. N., Albert, J., Baltes, P., et al. (2015) · Endoscopy · doi:10.1055/s-0034-1391855 · Cited by 897 · see citing works

Adalimumab for induction of clinical remission in moderately to severely active ulcerative colitis: results of a randomised controlled trial

Reinisch, W., Sandborn, W. J., Hommes, D. W., D’Haens, G., Hanauer, S. B., Schreiber, S., Panaccione, R., Fedorak, R. N., Tighe, M. B., Huang, B., et al. (2011) · Gut · doi:10.1136/gut.2010.221127 · Cited by 891 · see citing works

Methods for measuring and monitoring medication regimen adherence in clinical trials and clinical practice

Farmer, K. C. (1999) · Clinical Therapeutics · doi:10.1016/s0149-2918(99)80026-5 · Cited by 889 · see citing works

Trough Concentrations of Infliximab Guide Dosing for Patients With Inflammatory Bowel Disease

Casteele, N. V., Ferrante, M., Assche, G. V., Ballet, V., Compernolle, G., Steen, K. V., Simoens, S., Rutgeerts, P. J., Gils, A., & Vermeire, S. (2015) · Gastroenterology · doi:10.1053/j.gastro.2015.02.031 · Cited by 889 · see citing works

Risk of Surgery for Inflammatory Bowel Diseases Has Decreased Over Time: A Systematic Review and Meta-analysis of Population-Based Studies

Frolkis, A. D., Dykeman, J., Negrón, M. E., deBruyn, J. C. C., Jetté, N., Fiest, K. M., Frolkis, T. S., Barkema, H. W., Rioux, K. P., Panaccione, R., et al. (2013) · Gastroenterology · doi:10.1053/j.gastro.2013.07.041 · Cited by 887 · see citing works

Development and validation of an endoscopic index of the severity for Crohn's disease: a prospective multicentre study. Groupe d'Etudes Thérapeutiques des Affections Inflammatoires du Tube Digestif (GETAID).

Mary, J. Y., & Modigliani, R. (1989) · Gut · doi:10.1136/gut.30.7.983 · Cited by 887 · see citing works

Second European evidence-based consensus on the diagnosis and management of ulcerative colitis Part 1: Definitions and diagnosis

Dignass, A. U., Eliakim, R., Magro, F., Maaser, C., Chowers, Y., Geboes, K., Mantzaris, G. J., Reinisch, W., Colombel, J., Vermeire, S., et al. (2012) · Journal of Crohn s and Colitis · doi:10.1016/j.crohns.2012.09.003 · Cited by 885 · see citing works

Predictors of Crohn’s Disease

Beaugerie, L., Seksik, P., Nion–Larmurier, I., Gendre, J., & Cosnes, J. (2006) · Gastroenterology · doi:10.1053/j.gastro.2005.12.019 · Cited by 863 · see citing works

Effect of Fecal Microbiota Transplantation on 8-Week Remission in Patients With Ulcerative Colitis

Costello, S. P., Hughes, P. A., Waters, O. R., Bryant, R. V., Vincent, A. D., Blatchford, P. A., Katsikeros, R., Makanyanga, J. C., Campaniello, M. A., Mavrangelos, C., et al. (2019) · JAMA · doi:10.1001/jama.2018.20046 · Cited by 855 · see citing works

UK clinical guideline for the prevention and treatment of osteoporosis

The National Osteoporosis Guideline Group (NOGG), Compston, J. E., Cooper, A., Cooper, C. C., Gittoes, N. J. L., Gregson, C. L., Harvey, N. C., Hope, S., Kanis, J. А., McCloskey, E. V., et al. (2017) · Archives of Osteoporosis · doi:10.1007/s11657-017-0324-5 · Cited by 837 · see citing works

Mucosal Healing Predicts Sustained Clinical Remission in Patients With Early-Stage Crohn's Disease

Baert, F., Moortgat, L., Assche, G. V., Caenepeel, P., Vergauwe, P. L., Vos, M. D., Stokkers, P. C. F., Hommes, D. W., Rutgeerts, P. J., Vermeire, S., et al. (2009) · Gastroenterology · doi:10.1053/j.gastro.2009.09.056 · Cited by 829 · see citing works

The First European Evidence-based Consensus on Extra-intestinal Manifestations in Inflammatory Bowel Disease

Harbord, M., Annese, V., Vavricka, S. R., Allez, M., Acosta, M. B., Boberg, K. M., Burisch, J. M., Vos, M. D., de Vries, A., Dick, A. D., et al. (2015) · Journal of Crohn s and Colitis · doi:10.1093/ecco-jcc/jjv213 · Cited by 827 · see citing works

Switching from originator infliximab to biosimilar CT-P13 compared with maintained treatment with originator infliximab (NOR-SWITCH): a 52-week, randomised, double-blind, non-inferiority trial

Jørgensen, K. K., Olsen, I. C., Goll, G. L., Lorentzen, M., Bolstad, N., Haavardsholm, E. A., Lundin, K. E. A., Mørk, C., Jahnsen, J., Kvien, T. K., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)30068-5 · Cited by 822 · see citing works

European evidence based consensus for endoscopy in inflammatory bowel disease

Annese, V., Daperno, M., Rutter, M. D., Amiot, A., Bossuyt, P. J., East, J. E., Ferrante, M., Goetz, M., Katsanos, K. H., Kießlich, R., et al. (2013) · Journal of Crohn s and Colitis · doi:10.1016/j.crohns.2013.09.016 · Cited by 813 · see citing works

Mucosal healing in inflammatory bowel diseases: a systematic review

Neurath, M. F., & Travis, S. P. L. (2012) · Gut · doi:10.1136/gutjnl-2012-302830 · Cited by 808 · see citing works

The safety of vedolizumab for ulcerative colitis and Crohn's disease

Colombel, J., Sands, B. E., Rutgeerts, P. J., Sandborn, W. J., Danese, S., D’Haens, G., Panaccione, R., Loftus, E. V., Sankoh, S., Fox, I. H., et al. (2016) · Gut · doi:10.1136/gutjnl-2015-311079 · Cited by 805 · see citing works

Tofacitinib, an Oral Janus Kinase Inhibitor, in Active Ulcerative Colitis

Sandborn, W. J., Ghosh, S. K., Panés, J., Vranic, I. I., Su, C. G., Rousell, S., & Niezychowski, W. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1112168 · Cited by 800 · see citing works

Serious Infection and Mortality in Patients With Crohn's Disease: More Than 5 Years of Follow-Up in the TREAT™ Registry

Lichtenstein, G. R., Feagan, B. G., Cohen, R. D., Salzberg, B. A., Diamond, R. H., Price, S., Langholff, W. K., Londhe, A., & Sandborn, W. J. (2012) · The American Journal of Gastroenterology · doi:10.1038/ajg.2012.218 · Cited by 791 · see citing works

Histologic Inflammation Is a Risk Factor for Progression to Colorectal Neoplasia in Ulcerative Colitis: A Cohort Study

Gupta, R. B., Harpaz, N., Itzkowitz, S. H., Hossain, S., Matula, S. R., Kornbluth, A. A., Bodian, C., & Ullman, T. A. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.08.001 · Cited by 789 · see citing works

Predicting outcome in severe ulcerative colitis.

Travis, S. P. L., Farrant, J. M., Ricketts, C., Nolan, D. J., Mortensen, N. M., Kettlewell, M. G. W., & Jewell, D. P. (1996) · Gut · doi:10.1136/gut.38.6.905 · Cited by 787 · see citing works

Natural history of recurrent Crohn's disease at the ileocolonic anastomosis after curative surgery.

Rutgeerts, P., Geboes, K. P., Vantrappen, G. R., Kerremans, R., Coenegrachts, J. L., & Coremans, G. (1984) · Gut · doi:10.1136/gut.25.6.665 · Cited by 785 · see citing works

SCENIC International Consensus Statement on Surveillance and Management of Dysplasia in Inflammatory Bowel Disease

Laine, L., Kaltenbach, T. R., Barkun, A. N., McQuaid, K. R., Subramanian, V., Soetikno, R. M., East, J. E., Farraye, F. A., Feagan, B. G., Ioannidis, J. P. A., et al. (2015) · Gastroenterology · doi:10.1053/j.gastro.2015.01.031 · Cited by 779 · see citing works

Pouchitis After Ileal Pouch-Anal Anastomosis: A Pouchitis Disease Activity Index

Sandborn, W. J., Tremaine, W. J., Batts, K. P., Pembérton, J. H., & Phillips, S. F. (1994) · Mayo Clinic Proceedings · doi:10.1016/s0025-6196(12)61634-6 · Cited by 777 · see citing works

Expanded Adipose-Derived Stem Cells for the Treatment of Complex Perianal Fistula

García‐Olmo, D., Herreros, D., Pascual, I., Pascual, J. A., Valle-Hernandez, E. D., Zorrilla, J., De-La-Quintana, P., García‐Arranz, M., & Pascual, M. (2009) · Diseases of the Colon & Rectum · doi:10.1007/dcr.0b013e3181973487 · Cited by 773 · see citing works

3rd European Evidence-based Consensus on the Diagnosis and Management of Crohn’s Disease 2016: Part 2: Surgical Management and Special Situations

Gionchetti, P., Dignass, A. U., Danese, S., Dias, F. J. M., Rogler, G., Lakatos, P. L., Adamina, M., Ardizzone, S., Buskens, C. J., Sebastian, S., et al. (2016) · Journal of Crohn s and Colitis · doi:10.1093/ecco-jcc/jjw169 · Cited by 772 · see citing works

Strongyloides stercoralis: Global Distribution and Risk Factors

Schär, F., Trostdorf, U., Giardina, F., et al. (2013) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0002288 · Cited by 752 · see citing works

A Comparison of Methotrexate with Placebo for the Maintenance of Remission in Crohn's Disease

Feagan, B. G., Fedorak, R. N., Irvine, E. J., Wild, G., Sutherland, L. R., Steinhart, A. H., Greenberg, G. R., Koval, J. J., Wong, C. J., Hopkins, M., et al. (2000) · New England Journal of Medicine · doi:10.1056/nejm200006013422202 · Cited by 746 · see citing works

Controlled trial of metronidazole treatment for prevention of crohn's recurrence after ileal resection

Rutgeerts, P., Hiele, M., Geboes, K., Peeters, M., Penninckx, F., Aerts, R., & Kerremans, R. (1995) · Gastroenterology · doi:10.1016/0016-5085(95)90121-3 · Cited by 743 · see citing works

Trichuris suis therapy for active ulcerative colitis: A randomized controlled trial

Summers, R. W., Elliott, D. E., Urban, J. F., Thompson, R. A., & Weinstock, J. V. (2005) · Gastroenterology · doi:10.1053/j.gastro.2005.01.005 · Cited by 739 · see citing works

Venous thromboembolism during active disease and remission in inflammatory bowel disease: a cohort study

Grainge, M. J., West, J., & Card, T. R. (2010) · The Lancet · doi:10.1016/s0140-6736(09)61963-2 · Cited by 729 · see citing works

ESPEN guidelines on chronic intestinal failure in adults

Pironi, L., Arends, J., Bozzetti, F., Cuerda, C., Gillanders, L. K., Jeppesen, P. B., Joly, F., Kelly, D. G., Lal, S., Staun, M., et al. (2016) · Clinical Nutrition · doi:10.1016/j.clnu.2016.01.020 · Cited by 725 · see citing works

The Diagnostic Approach to Monogenic Very Early Onset Inflammatory Bowel Disease

Uhlig, H. H., Schwerd, T., Koletzko, S., Shah, N., Kammermeier, J., Elkadri, A. A., Ouahed, J., Wilson, D. C., Travis, S. P. L., Turner, D., et al. (2014) · Gastroenterology · doi:10.1053/j.gastro.2014.07.023 · Cited by 716 · see citing works

Ileal Pouch Anal Anastomosis

Fazio, V. W., Kiran, R. P., Remzi, F. H., Coffey, J. C., Heneghan, H., Kirat, H. T., Manilich, E. A., Shen, B., & Martin, S. (2013) · Annals of Surgery · doi:10.1097/sla.0b013e31827d99a2 · Cited by 712 · see citing works

Curcumin Maintenance Therapy for Ulcerative Colitis: Randomized, Multicenter, Double-Blind, Placebo-Controlled Trial

Hanai, H., Iida, T., Takeuchi, K., Watanabe, F., Maruyama, Y., Andoh, A., Tsujikawa, T., Fujiyama, Y., Mitsuyama, K., Sata, M., et al. (2006) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2006.08.008 · Cited by 704 · see citing works

Predictors of anti-TNF treatment failure in anti-TNF-naive patients with active luminal Crohn's disease: a prospective, multicentre, cohort study

Kennedy, N. A., Heap, G., Green, H., et al. (2019) · ˜The œLancet. Gastroenterology & hepatology · doi:10.1016/s2468-1253(19)30012-3 · Cited by 697 · see citing works

C-Reactive Protein, Fecal Calprotectin, and Stool Lactoferrin for Detection of Endoscopic Activity in Symptomatic Inflammatory Bowel Disease Patients: A Systematic Review and Meta-Analysis

Mosli, M. H., Zou, G., Garg, S. K., Feagan, S. G., MacDonald, J. K., Chande, N., Sandborn, W. J., & Feagan, B. G. (2015) · The American Journal of Gastroenterology · doi:10.1038/ajg.2015.120 · Cited by 692 · see citing works

Course of ulcerative colitis: Analysis of changes in disease activity over years

Langholz, E., Munkholm, P., Davidsen, M., & Binder, V. (1994) · Gastroenterology · doi:10.1016/0016-5085(94)90054-x · Cited by 689 · see citing works

A review of activity indices and efficacy endpoints for clinical trials of medical therapy in adults with Crohn's disease

Sandborn, W. J., Feagan, B. G., Hanauer, S. B., Lochs, H. H., Löfberg, R., Modigliani, R., Present, D. H., Rutgeerts, P. J., Schölmerich, J., Stange, E. F., et al. (2002) · Gastroenterology · doi:10.1053/gast.2002.31072 · Cited by 687 · see citing works

Clinical Pharmacogenetics Implementation Consortium Guideline for Thiopurine Dosing Based on TPMT and NUDT 15 Genotypes: 2018 Update

Relling, M. V., Schwab, M. G., Whirl‐Carrillo, M., et al. (2018) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.1304 · Cited by 687 · see citing works

A.S.P.E.N. clinical guidelines: Nutrition screening, assessment, and intervention in adults.

Mueller, C., Compher, C., & Ellen, D. M. (2013) · JPEN - Journal of Parenteral and Enteral Nutrition · doi:10.1177/0148607110389335 · Cited by 678 · see citing works

Mucosal healing predicts long-term outcome of maintenance therapy with infliximab in Crohnʼs disease

Schnitzler, F., Fidder, H. H., Ferrante, M., Noman, M., Arijs, I., Assche, G. V., Hoffman, I. E. A., Steen, K. V., Vermeire, S., & Rutgeerts, P. J. (2009) · Inflammatory Bowel Diseases · doi:10.1002/ibd.20927 · Cited by 671 · see citing works

Response to Corticosteroids in Severe Ulcerative Colitis: A Systematic Review of the Literature and a Meta-Regression

Turner, D., Walsh, C. M., Steinhart, A. H., & Griffiths, A. M. (2006) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2006.09.033 · Cited by 659 · see citing works

Systematic review: the use of ultrasonography, computed tomography and magnetic resonance imaging for the diagnosis, assessment of activity and abdominal complications of Crohn’s disease

Panés, J., Bouzas, R., Chaparro, M., García‐Sánchez, V., Gisbert, J. P., de Guereñu, B. M., Mendoza, J. L., Paredes, J. M. R., Quiroga, S., Ripollés, T., et al. (2011) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2011.04710.x · Cited by 658 · see citing works

National Institute for Health and Care Excellence.

Cowie, M. (2015) · PubMed · Cited by 651 · see citing works

Ciclosporin versus infliximab in patients with severe ulcerative colitis refractory to intravenous steroids: a parallel, open-label randomised controlled trial

Laharie, D., Bourreille, A., Branche, J., Allez, M., Bouhnik, Y., Filippi, J., Zerbib, F., Savoye, G., Nachury, M., Moreau, J., et al. (2012) · The Lancet · doi:10.1016/s0140-6736(12)61084-8 · Cited by 644 · see citing works

European Consensus on the Diagnosis and Management of Iron Deficiency and Anaemia in Inflammatory Bowel Diseases

Dignass, A. U., Gasché, C., Bettenworth, D., Birgegård, G., Danese, S., Gisbert, J. P., Gomollón, F., Iqbal, T. H., Katsanos, K. H., Κoutroubakis, I. E., et al. (2014) · Journal of Crohn s and Colitis · doi:10.1093/ecco-jcc/jju009 · Cited by 635 · see citing works

Developing an instrument to assess the endoscopic severity of ulcerative colitis: the Ulcerative Colitis Endoscopic Index of Severity (UCEIS)

Travis, S. P. L., Schnell, D. J., Krzeski, P., Abreu, M. T., Altman, D. G., Colombel, J., Feagan, B. G., Hanauer, S. B., Lémann, M., Lichtenstein, G. R., et al. (2011) · Gut · doi:10.1136/gutjnl-2011-300486 · Cited by 631 · see citing works

Inflammatory Bowel Disease Diagnosed with US, MR, Scintigraphy, and CT: Meta-analysis of Prospective Studies

Horsthuis, K., Bipat, S., Bennink, R. J., & Stoker, J. (2008) · Radiology · doi:10.1148/radiol.2471070611 · Cited by 629 · see citing works

Meta‐analysis: colorectal and small bowel cancer risk in patients with Crohn's disease

Canavan, C., Abrams, K. R., & Mayberry, J. F. (2006) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2006.02854.x · Cited by 622 · see citing works

Small intestinal bacterial overgrowth syndrome

Bures, J. (2010) · World Journal of Gastroenterology · doi:10.3748/wjg.v16.i24.2978 · Cited by 620 · see citing works

Genotypic analysis of thiopurine S-methyltransferase in patients with Crohn's disease and severe myelosuppression during azathioprine therapy

Colombel, J., Ferrari, N., Debuysère, H., et al. (2000) · Gastroenterology · doi:10.1016/s0016-5085(00)70354-4 · Cited by 619 · see citing works

Crohn's disease management after intestinal resection: a randomised trial

Cruz, P. P. D., Kamm, M. A., Hamilton, A. L., Ritchie, K. J., Krejany, E. O., Gorelik, A., Liew, D., Prideaux, L., Lawrance, I. C., Andrews, J. M., et al. (2014) · The Lancet · doi:10.1016/s0140-6736(14)61908-5 · Cited by 618 · see citing works

Prevalence of symptoms meeting criteria for irritable bowel syndrome in inflammatory bowel disease: systematic review and meta-analysis

Halpin, S. J., & Ford, A. C. (2012) · American Journal of Gastroenterology · doi:10.1038/ajg.2012.260 · Cited by 607 · see citing works

Enteral nutritional therapy for induction of remission in Crohn's disease

Zachos, M., Tondeur, M. C., & Griffiths, A. M. (2007) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000542.pub2 · Cited by 598 · see citing works

Infliximab Prevents Crohn's Disease Recurrence After Ileal Resection

Regueiro, M. D., Schraut, W. H., Baidoo, L., Kip, K. E., Sepulveda, A. R., Pesci, M., Harrison, J., & Plevy, S. E. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.10.051 · Cited by 598 · see citing works

Maintenance of Remission Among Patients With Crohn's Disease on Antimetabolite Therapy After Infliximab Therapy Is Stopped

Louis, E. J., Mary, J., Vernier-Massouille, G., Grimaud, J., Bouhnik, Y., Laharie, D., Dupas, J., Pillant, H., Picon, L., Veyrac, M., et al. (2011) · Gastroenterology · doi:10.1053/j.gastro.2011.09.034 · Cited by 593 · see citing works

Increased Risk of Intestinal Cancer in Crohn's Disease: A Meta-Analysis of Population-Based Cohort Studies

Jess, T., Gamborg, M., Matzen, P., Munkholm, P. S., & Sorensen, T. I. A. (2005) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2005.00287.x · Cited by 587 · see citing works

Development of the Crohnʼs disease digestive damage score, the Lémann score

Pariente, B., Cosnes, J., Danese, S., Sandborn, W. J., Lewin, M., Fletcher, J. G., Chowers, Y., D’Haens, G., Feagan, B. G., Hibi∥, T., et al. (2010) · Inflammatory Bowel Diseases · doi:10.1002/ibd.21506 · Cited by 584 · see citing works

A comparison of endoscopic ultrasound, magnetic resonance imaging, and exam under anesthesia for evaluation of Crohn's perianal fistulas

Schwartz, D. A., Wiersema, M. J., Dudiak, K. M., et al. (2001) · Gastroenterology · doi:10.1053/gast.2001.28676 · Cited by 578 · see citing works

2017 American College of Rheumatology Guideline for the Prevention and Treatment of Glucocorticoid‐Induced Osteoporosis

Buckley, L. M., Guyatt, G. H., Fink, H. A., Cannon, M. D., Grossman, J., Hansen, K. E., Humphrey, M. B., Lane, N. E., Magrey, M., Miller, M. A., et al. (2017) · Arthritis Care & Research · doi:10.1002/acr.23279 · Cited by 578 · see citing works

Adalimumab Induces and Maintains Mucosal Healing in Patients With Crohn's Disease: Data From the EXTEND Trial

Rutgeerts, P. J., Assche, G. V., Sandborn, W. J., Wolf, D. C., Geboes, K. J., Colombel, J., Reinisch, W., Kumar, A., Lazar, A., Camez, A. A., et al. (2012) · Gastroenterology · doi:10.1053/j.gastro.2012.01.035 · Cited by 577 · see citing works

Impact of Clostridium difficile on Inflammatory Bowel Disease

Issa, M., Vijayapal, A., Graham, M. B., Beaulieu, D. B., Otterson, M. F., Lundeen, S. J., Skaros, S., Weber, L. R., KOMOROWSKI, R. A., Knox, J. F., et al. (2007) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2006.12.028 · Cited by 570 · see citing works

Antibiotic therapy in inflammatory bowel disease: A systematic review and meta-analysis

Khan, K. J., Ullman, T. A., Ford, A. C., Abreu, M. T., Abadir, A., Marshall, J. K., Talley, N. J., & Moayyedi, P. (2011) · American Journal of Gastroenterology · doi:10.1038/ajg.2011.72 · Cited by 569 · see citing works

Medication nonadherence and the outcomes of patients with quiescent ulcerative colitis

Kane, S. V., Huo, D., Aikens, J. E., & Hanauer, S. B. (2003) · The American Journal of Medicine · doi:10.1016/s0002-9343(02)01383-9 · Cited by 568 · see citing works

Pouchitis after ileal pouch-anal anastomosis for ulcerative colitis occurs with increased frequency in patients with associated primary sclerosing cholangitis.

Penna, C., Dozois, R. R., Tremaine, W. J., Sandborn, W. J., LaRusso, N. A., Schleck, C. D., & Ilstrup, D. M. (1996) · Gut · doi:10.1136/gut.38.2.234 · Cited by 559 · see citing works

Inflammation and colorectal cancer: colitis-associated neoplasia

Grivennikov, S. I. (2012) · Seminars in Immunopathology · doi:10.1007/s00281-012-0352-6 · Cited by 555 · see citing works

Peripheral arthropathies in inflammatory bowel disease: their articular distribution and natural history

Orchard, T. R., Wordsworth, B. P., & Jewell, D. P. (1998) · Gut · doi:10.1136/gut.42.3.387 · Cited by 553 · see citing works

A common missense variant in NUDT15 confers susceptibility to thiopurine-induced leukopenia

Yang, S., Hong, M., Baek, J., Choi, H., Zhao, W., Jung, Y., Haritunians, T., Ye, B. D., Kim, K., Park, S. H., et al. (2014) · Nature Genetics · doi:10.1038/ng.3060 · Cited by 549 · see citing works

INTENSIVE INTRAVENOUS REGIMEN FOR SEVERE ATTACKS OF ULCERATIVE COLITIS

Truelove, S. C., & Jewell, D. P. (1974) · The Lancet · doi:10.1016/s0140-6736(74)90552-2 · Cited by 549 · see citing works

Anti-inflammatory and immunosuppressive drugs and reproduction

Østensen, M., Khamashta, M. A., Lockshin, M. D., Parke, A. L., Brucato, A. L., Carp, H., Doria, A., Rai, R., Meroni, P. L., Cetin, I., et al. (2006) · Arthritis Research & Therapy · doi:10.1186/ar1957 · Cited by 545 · see citing works

Trough serum infliximab: a predictive factor of clinical outcome for infliximab treatment in acute ulcerative colitis

Seow, C. H., Newman, A., Irwin, S. P., Steinhart, A. H., Silverberg, M. S., & Greenberg, G. R. (2009) · Gut · doi:10.1136/gut.2009.183095 · Cited by 535 · see citing works

Long-term outcome of treatment with infliximab in 614 patients with Crohn's disease: results from a single-centre cohort

Schnitzler, F., Fidder, H. H., Ferrante, M., Noman, M., Arijs, I., Assche, G. V., Hoffman, I. E. A., Steen, K. V., Vermeire, S., & Rutgeerts, P. (2008) · Gut · doi:10.1136/gut.2008.155812 · Cited by 534 · see citing works

AGA Medical Position Statement on the Diagnosis and Management of Colorectal Neoplasia in Inflammatory Bowel Disease

Farraye, F. A., Odze, R. D., Eaden, J., & Itzkowitz, S. H. (2010) · Gastroenterology · doi:10.1053/j.gastro.2009.12.037 · Cited by 530 · see citing works

Azathioprine and 6-mercaptopurine for maintenance of remission in ulcerative colitis

Timmer, A., Patton, P. H., Chande, N., McDonald, J. W., & MacDonald, J. K. (2016) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000478.pub4 · Cited by 529 · see citing works

2017 American College of Rheumatology Guideline for the Prevention and Treatment of Glucocorticoid‐Induced Osteoporosis

Buckley, L. M., Guyatt, G. H., Fink, H. A., Cannon, M. D., Grossman, J., Hansen, K. E., Humphrey, M. B., Lane, N. E., Magrey, M., Miller, M. A., et al. (2017) · Arthritis & Rheumatology · doi:10.1002/art.40137 · Cited by 527 · see citing works

Infliximab for the treatment of fistulas in patients with Crohn's disease

Ricart, E., & Sandborn, W. J. (1999) · Gastroenterology · doi:10.1016/s0016-5085(99)70414-2 · Cited by 524 · see citing works

Crohn's disease complicated by strictures: a systematic review

Rieder, F., Zimmermann, E. M., Remzi, F. H., & Sandborn, W. J. (2013) · Gut · doi:10.1136/gutjnl-2012-304353 · Cited by 514 · see citing works

Transdermal Nicotine for Active Ulcerative Colitis

Pullan, R. D., Rhodes, J., Ganesh, S., Mani, V., Morris, J. S., Williams, G. T., Newcombe, R. G., Russell, M., Feyerabend, C., Thomas, G., et al. (1994) · New England Journal of Medicine · doi:10.1056/nejm199403243301202 · Cited by 505 · see citing works

Magnetic resonance imaging for evaluation of Crohnʼs disease

Rimola, J., Ordás, Í., Rodríguez, S., García‐Bosch, O., Aceituno, M., Llach, J., Ayuso, C., Ricart, E., & Panés, J. (2010) · Inflammatory Bowel Diseases · doi:10.1002/ibd.21551 · Cited by 503 · see citing works

Natural History of Adult Ulcerative Colitis in Population-based Cohorts: A Systematic Review

Fumery, M., Singh, S., Dulai, P. S., Gower‐Rousseau, C., Peyrin‐Biroulet, L., & Sandborn, W. J. (2017) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2017.06.016 · Cited by 500 · see citing works

Placental Transfer of Anti–Tumor Necrosis Factor Agents in Pregnant Patients With Inflammatory Bowel Disease

Mahadevan, U., Wolf, D. C., Dubinsky, M. C., et al. (2012) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2012.11.011 · Cited by 499 · see citing works

Risk of Intestinal Cancer in Inflammatory Bowel Disease: A Population-Based Study From Olmsted County, Minnesota

Jess, T., Loftus, E. V., Velayos, F. S., Harmsen, W. S., Zinsmeister, A. R., Smyrk, T. C., Schleck, C. D., Tremaine, W. J., Melton, L. J., Munkholm, P. S., et al. (2006) · Gastroenterology · doi:10.1053/j.gastro.2005.12.037 · Cited by 497 · see citing works

Natural course of Crohn's disease after ileocolic resection: endoscopically visualised ileal ulcers preceding symptoms.

Olaison, G., Smedh, K., & Sjödahl, R. (1992) · Gut · doi:10.1136/gut.33.3.331 · Cited by 497 · see citing works

Oral 5-aminosalicylic acid for induction of remission in ulcerative colitis

Wang, Y., Parker, C. E., Bhanji, T., Feagan, B. G., & MacDonald, J. K. (2016) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000543.pub4 · Cited by 492 · see citing works

Long-term Efficacy and Safety of Stem Cell Therapy (Cx601) for Complex Perianal Fistulas in Patients With Crohn’s Disease

Panés, J., García-Olmo, D., Assche, G. V., Colombel, J. F., Reinisch, W., Baumgart, D. C., Dignass, A. U., Nachury, M., Ferrante, M., Kazemi-Shirazi, L., et al. (2017) · Gastroenterology · doi:10.1053/j.gastro.2017.12.020 · Cited by 483 · see citing works

Oral 5-aminosalicylic acid for maintenance of remission in ulcerative colitis

Wang, Y., Parker, C. E., Feagan, B. G., & MacDonald, J. K. (2016) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000544.pub4 · Cited by 482 · see citing works

6-MP metabolite profiles provide a biochemical explanation for 6-MP resistance in patients with inflammatory bowel disease

Dubinsky, M. C., Yang, H., Hassard, P. V., Seidman, E. G., Kam, L. Y., Abreu, M. T., Targan, S. R., & Vasiliauskas, E. A. (2002) · Gastroenterology · doi:10.1053/gast.2002.32420 · Cited by 481 · see citing works

The Second European Evidenced-Based Consensus on Reproduction and Pregnancy in Inflammatory Bowel Disease

van der Woude, C. J., Ardizzone, S., Bengtson, M., Fiorino, G., FRASER, G. M., Katsanos, K. H., Kolaček, S., Juillerat, P., Mulders, A. G. M. G. J., Pedersen, N., et al. (2014) · Journal of Crohn s and Colitis · doi:10.1093/ecco-jcc/jju006 · Cited by 475 · see citing works

The Toronto Consensus Statements for the Management of Inflammatory Bowel Disease in Pregnancy

Nguyen, G. C., Seow, C. H., Maxwell, C. V., Huang, V., Leung, Y., Jones, J., Leontiadis, G. I., Tse, F., Mahadevan, U., van der Woude, C. J., et al. (2015) · Gastroenterology · doi:10.1053/j.gastro.2015.12.003 · Cited by 470 · see citing works

Polymeric Diet Alone Versus Corticosteroids in the Treatment of Active Pediatric Crohn’s Disease: A Randomized Controlled Open-Label Trial

Borrelli, O., Cordischi, L., Cirulli, M., Paganelli, M., Labalestra, V., Uccini, S., Russo, P. M., & Cucchiara, S. (2006) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2006.03.010 · Cited by 469 · see citing works

Quality of Care Management Decisions by Multidisciplinary Cancer Teams: A Systematic Review

Lamb, B. W., Brown, K., Nagpal, K., Vincent, C. A., Green, J. S. A., & Sevdalis, N. (2011) · Annals of Surgical Oncology · doi:10.1245/s10434-011-1675-6 · Cited by 466 · see citing works

Second European evidence-based consensus on the diagnosis and management of ulcerative colitis Part 3: Special situations

Assche, G. V., Dignass, A. U., Bokemeyer, B., Danese, S., Gionchetti, P., Moser, G., Beaugerie, L., Gomollón, F., Häuser, W., Herrlinger, K. R., et al. (2012) · Journal of Crohn s and Colitis · doi:10.1016/j.crohns.2012.09.005 · Cited by 461 · see citing works

Individualised therapy is more cost-effective than dose intensification in patients with Crohn’s disease who lose response to anti-TNF treatment: a randomised, controlled trial

Steenholdt, C., Brynskov, J., Thomsen, O. Ø., Munck, L. K., Fallingborg, J., Christensen, L. A., Pedersen, G., Kjeldsen, J., Jacobsen, B. A., Oxholm, A. S., et al. (2013) · Gut · doi:10.1136/gutjnl-2013-305279 · Cited by 459 · see citing works

Obesity in IBD: epidemiology, pathogenesis, disease course and treatment outcomes

Singh, S., Dulai, P. S., Zarrinpar, A., Ramamoorthy, S. L., & Sandborn, W. J. (2016) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2016.181 · Cited by 456 · see citing works

Reliability and Initial Validation of the Ulcerative Colitis Endoscopic Index of Severity

Travis, S. P. L., Schnell, D. J., Krzeski, P., Abreu, M. T., Altman, D. G., Colombel, J., Feagan, B. G., Hanauer, S. B., Lichtenstein, G. R., Marteau, P. R., et al. (2013) · Gastroenterology · doi:10.1053/j.gastro.2013.07.024 · Cited by 456 · see citing works

Defining Disease Severity in Inflammatory Bowel Diseases: Current and Future Directions

Peyrin‐Biroulet, L., Panés, J., Sandborn, W. J., Vermeire, S., Danese, S., Feagan, B. G., Colombel, J., Hanauer, S. B., & Rycroft, B. (2015) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2015.06.001 · Cited by 455 · see citing works

Randomised controlled trial of azathioprine withdrawal in ulcerative colitis.

Hawthorne, A. B., Logan, R. F., Hawkey, C. J., Foster, P. N., Axon, A. T. R., Swarbrick, E. T., Scott, B. B., & Lennard‐Jones, J. E. (1992) · BMJ · doi:10.1136/bmj.305.6844.20 · Cited by 451 · see citing works

Randomized, double-blind comparison of 4 mg/kg versus 2 mg/kg intravenous cyclosporine in severe ulcerative colitis1 1Gert Van Assche, Severine Vermeire, Geert D’Haens, and Paul Rutgeerts have been instrumental in the design of the study, trial management, data analysis, and writing the paper. Maja Noman had a major contribution in the clinical ambulatory follow-up of the patients in the trial. Martin Hiele followed cyclosporine levels and adjusted drug doses of patients in the trial and provided statistical advice. Katrien Asnong was the study coordinator and had a major share in data analysis. Joris Arts analyzed safety data and followed patients clinically during the trial. Andre D’Hoore and Freddy Penninckx performed the surgical interventions in patients failing the trial and substantially contributed in evaluating patients for colectomy.

Assche, G. V., D’Haens, G., Noman, M., Vermeire, S., Hiele, M. I., Asnong, K., Arts, J., D’Hoore, A., PENNINCKX, F. M., & Rutgeerts, P. J. (2003) · Gastroenterology · doi:10.1016/s0016-5085(03)01214-9 · Cited by 449 · see citing works

Epidemiologic analysis of Crohn disease in Japan: increased dietary intake of n-6 polyunsaturated fatty acids and animal protein relates to the increased incidence of Crohn disease in Japan

Shoda, R., Matsueda, K., Yamato, S., & Umeda, N. (1996) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/63.5.741 · Cited by 444 · see citing works

Small-bowel capsule endoscopy and device-assisted enteroscopy for diagnosis and treatment of small-bowel disorders: European Society of Gastrointestinal Endoscopy (ESGE) Technical Review

Rondonotti, E., Spada, C., Adler, S. N., May, A., Despott, E. J., Koulaouzidis, A., Panter, S. J., Domagk, D., Fernández-Urién, I., Rahmi, G., et al. (2018) · Endoscopy · doi:10.1055/a-0576-0566 · Cited by 443 · see citing works

Cancer surveillance in longstanding ulcerative colitis: endoscopic appearances help predict cancer risk

Rutter, M. D., Saunders, B. P., Wilkinson, K. H., Rumbles, S., Schofield, G., Kamm, M. A., Williams, C. B., Price, A. B., Talbot, I. C., & Forbes, A. (2004) · Gut · doi:10.1136/gut.2003.038505 · Cited by 441 · see citing works

The Manitoba IBD Cohort Study: A Population-Based Study of the Prevalence of Lifetime and 12-Month Anxiety and Mood Disorders

Walker, J. R., Ediger, J. P., Graff, L. A., Greenfeld, J. M., Clara, I., Lix, L., Rawsthorne, P., Miller, N., Rogala, L., McPhail, C. M., et al. (2008) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2008.01980.x · Cited by 437 · see citing works

BTS recommendations for assessing risk and for managing Mycobacterium tuberculosis infection and disease in patients due to start anti-TNF- treatment

(2005) · Thorax · doi:10.1136/thx.2005.046797 · Cited by 437 · see citing works

Iron Absorption from Oral Iron Supplements given on Consecutive versus Alternate Days and as Single Morning Doses versus Twice-Daily Split Dosing in Iron-Depleted Women: Two Open-Label, Randomised Controlled Trials

Stoffel, N. U., Cercamondi, C. I., Brittenham, G., Zeder, C., Geurts-Moespot, A. J., Swinkels, D. W., Moretti, D., & Zimmermann, M. B. (2017) · The Lancet Haematology · doi:10.1016/s2352-3026(17)30182-5 · Cited by 435 · see citing works

Curcumin in Combination With Mesalamine Induces Remission in Patients With Mild-to-Moderate Ulcerative Colitis in a Randomized Controlled Trial

Lang, A., Salomon, N., Wu, J. C., Kopylov, U., Lahat, A., Har‐Noy, O., Ching, J. Y. L., Cheong, P. K., Avidan, B., Gamus, D., et al. (2015) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2015.02.019 · Cited by 434 · see citing works

SCENIC international consensus statement on surveillance and management of dysplasia in inflammatory bowel disease

Laine, L., Kaltenbach, T. R., Barkun, A. N., McQuaid, K. R., Subramanian, V., Soetikno, R. M., East, J. E., Farraye, F. A., Feagan, B. G., Ioannidis, J. P. A., et al. (2015) · Gastrointestinal Endoscopy · doi:10.1016/j.gie.2014.12.009 · Cited by 430 · see citing works

Excess hospitalisation burden associated with Clostridium difficile in patients with inflammatory bowel disease

Ananthakrishnan, A. N., McGinley, E. L., & Binion, D. G. (2007) · Gut · doi:10.1136/gut.2007.128231 · Cited by 429 · see citing works

Prevalence of nonadherence with maintenance mesalamine in quiescent ulcerative colitis

Kane, S. V., Cohen, R. D., Aikens, J. E., & Hanauer, S. B. (2001) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2001.04683.x · Cited by 429 · see citing works

European Evidence-based Consensus: Inflammatory Bowel Disease and Malignancies

Annese, V., Beaugerie, L., Egan, L. J., Biancone, L., Bolling, C., Brandts, C., Dierickx, D., Dummer, R., Fiorino, G., Gornet, J. M., et al. (2015) · Journal of Crohn s and Colitis · doi:10.1093/ecco-jcc/jjv141 · Cited by 428 · see citing works

Pouchitis following heal pouch-anal anastomosis: Definition, pathogenesis, and treatment

Sandborn, W. J. (1994) · Gastroenterology · doi:10.1016/0016-5085(94)90832-x · Cited by 427 · see citing works

Animal Protein Intake and Risk of Inflammatory Bowel Disease: The E3N Prospective Study

Jantchou, P., Morois, S., Clavel‐Chapelon, F., Boutron‐Ruault, M., & Carbonnel, F. (2010) · The American Journal of Gastroenterology · doi:10.1038/ajg.2010.192 · Cited by 426 · see citing works

Overlap in the spectrum of non-specific inflammatory bowel disease--'colitis indeterminate'.

Price, A. B. (1978) · Journal of Clinical Pathology · doi:10.1136/jcp.31.6.567 · Cited by 418 · see citing works

Ornidazole for prophylaxis of postoperative Crohn’s disease recurrence: A randomized, double-blind, placebo-controlled trial

Rutgeerts, P. J., Assche, G. V., Vermeire, S., D’Haens, G., Baert, F., Noman, M., Aerden, I., Hertogh, G. D., Geboes, K. J., Hiele, M. I., et al. (2005) · Gastroenterology · doi:10.1053/j.gastro.2005.01.010 · Cited by 416 · see citing works

Tofacitinib versus etanercept or placebo in moderate-to-severe chronic plaque psoriasis: a phase 3 randomised non-inferiority trial

Bachelez, H., van de Kerkhof, P. C. M., Strohal, R., Kubanov, A. A., Valenzuela, F., Lee, J., Yakusevich, V. V., Chimenti, S., Papacharalambous, J., Proulx, J., et al. (2015) · The Lancet · doi:10.1016/s0140-6736(14)62113-9 · Cited by 413 · see citing works

Mucosal healing and a fall in mucosal pro‐inflammatory cytokine mRNA induced by a specific oral polymeric diet in paediatric Crohn’s disease

Fell, Paintin, Arnaud‐Battandier, Beattie, R. M., Hollis, Kitching, Donnet‐Hughes, MacDonald, & Walker‐Smith (2000) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.2000.00707.x · Cited by 407 · see citing works

The pattern and outcome of acute severe colitis

Dinesen, L. C., Walsh, A. J., Protic, M. N., Heap, G., Cummings, F. J. R., Warren, B. F., George, B. D., Mortensen, N. J. M., & Travis, S. P. L. (2010) · Journal of Crohn s and Colitis · doi:10.1016/j.crohns.2010.02.001 · Cited by 403 · see citing works

Clinical Practice Guidelines for the Use of Video Capsule Endoscopy

Enns, R. A., Hookey, L. C., Armstrong, D. G., et al. (2017) · Gastroenterology · doi:10.1053/j.gastro.2016.12.032 · Cited by 403 · see citing works

Azathioprine or 6-mercaptopurine for maintenance of remission in Crohn's disease

Chande, N., Patton, P. H., Tsoulis, D. J., Thomas, B., & MacDonald, J. K. (2015) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000067.pub3 · Cited by 402 · see citing works

A National Survey of the Prevalence and Impact of Clostridium difficile Infection Among Hospitalized Inflammatory Bowel Disease Patients

Nguyen, G. C., Kaplan, G. G., Harris, M. L., & Brant, S. R. (2008) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2007.01780.x · Cited by 400 · see citing works

Predictive and Protective Factors Associated With Colorectal Cancer in Ulcerative Colitis: A Case-Control Study

Velayos, F. S., Loftus, E. V., Jess, T., Harmsen, W. S., Bida, J. P., Zinsmeister, A. R., Tremaine, W. J., & Sandborn, W. J. (2006) · Gastroenterology · doi:10.1053/j.gastro.2006.03.028 · Cited by 399 · see citing works

Capsule Endoscopy Has a Significantly Higher Diagnostic Yield in Patients With Suspected and Established Small-Bowel Crohn's Disease: A Meta-Analysis

Dionisio, P. M., Gurudu, S., Leighton, J. A., et al. (2009) · The American Journal of Gastroenterology · doi:10.1038/ajg.2009.713 · Cited by 397 · see citing works

Long-term safety of tofacitinib for the treatment of rheumatoid arthritis up to 8.5 years: integrated analysis of data from the global clinical trials

Cohen, S. B., Tanaka, Y., Xavier Mariette, A., Curtis, J. R., Lee, E. B., Nash, P. T., Winthrop, K. L., Charles‐Schoeman, C., Thirunavukkarasu, K., DeMasi, R., et al. (2017) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2016-210457 · Cited by 396 · see citing works

A Meta-Analysis of the Utility of C-Reactive Protein, Erythrocyte Sedimentation Rate, Fecal Calprotectin, and Fecal Lactoferrin to Exclude Inflammatory Bowel Disease in Adults With IBS

Menees, S. B., Powell, C. C., Kurlander, J. E., Goel, A., & Chey, W. D. (2015) · The American Journal of Gastroenterology · doi:10.1038/ajg.2015.6 · Cited by 395 · see citing works

Intravenous cyclosporine versus intravenous corticosteroids as single therapy for severe attacks of ulcerative colitis

D’Haens, G., Lemmens, L., Nevens, F., Hiele, M. I., Rutgeerts, P. J., Vandeputte, L., Peeters, M., Vermeire, S., Geboes, K., Acker, F. V., et al. (2001) · Gastroenterology · doi:10.1053/gast.2001.23983 · Cited by 392 · see citing works

Biologic Therapies and Risk of Infection and Malignancy in Patients With Inflammatory Bowel Disease: A Systematic Review and Network Meta-analysis

Bonovas, S., Fiorino, G., Allocca, M., Lytras, T., Nikolopoulos, G. K., Peyrin‐Biroulet, L., & Danese, S. (2016) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2016.04.039 · Cited by 386 · see citing works

Clinical trial: vitamin D3 treatment in Crohn’s disease – a randomized double‐blind placebo‐controlled study

Jørgensen, S. P., Agnholt, J. S., Glerup, H., Lyhne, S., Villadsen, G. E., Hvas, C. L., Bartels, L. E., Kelsen, J., Christensen, L. A., & Dahlerup, J. F. (2010) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2010.04355.x · Cited by 382 · see citing works

Clinical Examination, Endosonography, and MR Imaging in Preoperative Assessment of Fistula in Ano: Comparison with Outcome-based Reference Standard

Buchanan, G. N., Halligan, S., Bartram, C. I., Williams, A. B., Tarroni, D., & Cohen, R. (2004) · Radiology · doi:10.1148/radiol.2333031724 · Cited by 376 · see citing works

Dietary fibre in gastrointestinal health and disease

Gill, S. K., Rossi, M., Bajka, B., & Whelan, K. (2021) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-020-00375-4 · Cited by 979 · see citing works

EASL Clinical Practice Guidelines on sclerosing cholangitis

Chazouilleres, O., Beuers, U., Bergquist, A., Karlsen, T. H., Levy, C., Samyn, M., Schramm, C., & Trauner, M. (2022) · Journal of Hepatology · doi:10.1016/j.jhep.2022.05.011 · Cited by 419 · see citing works

Inflammatory Bowel Disease and Colorectal Cancer: Epidemiology, Etiology, Surveillance, and Management

Sato, Y., Tsujinaka, S., Miura, T., Kitamura, Y., Suzuki, H., & Shibata, C. (2023) · Cancers · doi:10.3390/cancers15164154 · Cited by 111 · see citing works

Efficacy of psychological therapies in people with inflammatory bowel disease: a systematic review and meta-analysis

Riggott, C., Mikocka-Walus, A., Gracie, D. J., & Ford, A. C. (2023) · The Lancet Gastroenterology & Hepatology · doi:10.1016/s2468-1253(23)00186-3 · Cited by 83 · see citing works

Efficacy and safety of probiotics in IBD: An overview of systematic reviews and updated meta-analysis of randomized controlled trials.

Estevinho, M. M., Yuan, Y., Rodríguez‐Lago, I., Sousa‐Pimenta, M., Dias, C. C., Barreiro‐de Acosta, M., Jairath, V., & Magro, F. (2024) · United European gastroenterology journal · doi:10.1002/ueg2.12636 · Cited by 74 · see citing works

May ChatGPT be a tool producing medical information for common inflammatory bowel disease patients' questions? An evidence-controlled analysis

Gravina, A. G., Pellegrino, R., Cipullo, M., Palladino, G., Imperio, G., Ventura, A., Auletta, S., Ciamarra, P., & Federico, A. (2024) · World Journal of Gastroenterology · doi:10.3748/wjg.v30.i1.17 · Cited by 56 · see citing works

Causal relationship between bipolar disorder and inflammatory bowel disease: A bidirectional two-sample mendelian randomization study

Wang, Z., Wang, X., Zhao, X., Hu, Z., Sun, D., Wu, D., & Xing, Y. (2022) · Frontiers in Genetics · doi:10.3389/fgene.2022.970933 · Cited by 10 · see citing works

P0233 IMPACT OF LIVER TRANSPLANTATION ON RATE CORRECTED Q‐T INTERVAL IN PATIENTS WITH CHRONIC LIVER DISEASE

Arıkan, Ç., Tümgör, G., Levent, E., et al. (2004) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1002/j.1536-4801.2004.tb12663.x

P0379 CLINICAL UTILITY OF SERUM HYALURONIC ACID IN PEDIATRIC LIVER DISEASE

Süoğlu, Ö. D., Sökücü, S., Ozden, T., et al. (2004) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1002/j.1536-4801.2004.tb12809.x

P0691 DOES THE ASSOCIATION WITH AN AUTOIMMUNE DIGESTIVE DISEASE DEFINE AN AUTOIMMUNE COLITIS?

Talbotec, C., Canioni, D., Lacaille, F., et al. (2004) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1002/j.1536-4801.2004.tb13121.x

109 OUTCOME OF RESECTED CROHN'S DISEASE IN CHILDREN

Benkov, K. J., Schwersenz, A. H., Rosh, J. R., et al. (1994) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1002/j.1536-4801.1994.tb11412.x

Obesity in Children and Adolescents: Working Group Report of the Second World Congress of Pediatric Gastroenterology, Hepatology, and Nutrition

Fisberg, M., Baur, L. A., Chen, W. W., Hoppin, A. G., Koletzko, B. V., Lau, D. C. W., Moreno, L. A., Nelson, E. A. S., Strauss, R. S., & Uauy, R. D. (2004) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1002/j.1536-4801.2004.tb12237.x · Cited by 5 · see citing works